Prucalopride Succinate

PrucaloprideSuccinate is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.CIC is one of the most common chronic functional gastrointestinal disorders worldwide. Prucalopride Succinate Kimia Biosciences Ltd™ is engaged in manufacturing of bulk drugs addressing to various high potential therapeutic segments and has envisaged high growth plans through infrastructure creation and CMS. Kimia has earmarked significant investment for this over next two years to become one of the major players in the Indian market. Moving forward towards vertical integration we have plans to set up our own FFF facilities for lifestyle segments with international regulatory standards to be able to not only launch itself in ROW but advance markets as well in future times.